Di Minno, Giovanni, and Roberto Ravasio. 2021. “Cost-Effectiveness Analysis of Caplacizumab in the New Standard of Care for Immune Thrombotic Thrombocytopenic Purpura in Italy”. Global and Regional Health Technology Assessment 8 (1):43-52. https://doi.org/10.33393/grhta.2021.2191.